The European Union, EU, has committed 18 million Euros to aid vaccine research in Nigeria, as announced by Amb. Samuela Isopi, Head of the EU Delegation to Nigeria and ECOWAS.
The investment aligns with Nigeria’s priorities, unveiled during the presentation of the National Plan for Vaccine Research and Development and Local Production 2024-2034 in Abuja.
The National Institute for Pharmaceutical Research and Development (NIPRD) led the plan’s development with collaborative support from the EU and the Bulgarian Government.
Prof. Leila Mathieu, representing Isopi, emphasised the EU’s dedication, allocating 18 million euros as full grants for public research institutions and partners.
The EU aims to foster collaboration with Nigeria’s Ministry of Health and public institutions, fostering a Team Europe spirit with Bulgaria in the continental initiative for vaccine manufacturing.
Isopi also highlighted additional projects in Nigeria focused on public health institutions and digital health.
Bulgarian Ambassador to Nigeria, Amb. Yanko Yordanov, affirmed the long-term partnership between Bulgaria and Nigeria in the health sector, pledging support for the plan’s implementation.
Dr. Tunji Alausa, Minister of State for Health and Social Welfare, expressed gratitude for the generous efforts, emphasising the importance of local vaccine production in Nigeria.
He commended the partnership triggered by COVID-19, stressing the need to build capacity for sustainable healthcare.
